Teva Pharmaceutical Industries Limited ( TEVJF) - Stock Earnings
TEVJF Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 489.9 million USD | 4.7 billion USD |
| 2026Q1 | 369.0 million USD | 4.0 billion USD |
| 2026Q2 | -576.0 million USD | 4.1 billion USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
TEVJF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -559.0 million USD | 15.8 billion USD |
| 2024 | -1.6 billion USD | 16.5 billion USD |
| 2025 | 1.5 billion USD | 17.3 billion USD |
| 2026 Est. | — | — |
TEVJF
Price: $38.98
52 week price:
Dividend Yield: 3.01%
Payout Ratio Range:
Earnings Per Share: 0.60 USD
P/E Ratio: 47.33
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 45.4 billion